A. Raby

发表

The role of local CpG DNA methylation in mediating the 17q21 asthma-susceptibility GSDMB/ORMDL3 expression quantitative trait locus

D. Nicolae, S. London, F. Gilliland, 2018 .

Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors

C. Fielding, Simon A. Jones, M. Labéta, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complement takes its Toll: an inflammatory crosstalk between Toll‐like receptors and the receptors for the complement anaphylatoxin C5a

M. Labéta, J. Hall, A. Raby, 2012, Anaesthesia.

Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity

M. Labéta, A. Raby, 2018, Front. Physiol..

Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.

M. Labéta, N. Topley, D. Fraser, 2018, Kidney international.

Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission

Judith E. Hall, T. Szakmany, M. Labéta, 2017, Intensive Care Medicine Experimental.

Biochemical and functional study of the immunomodulatory capacity of the soluble form of human Toll-like receptor 2

A. Raby, 2008 .

Selective Antibody Intervention of Toll-like Receptor 4 Activation through Fc γ Receptor Tethering

W. Reith, A. Geinoz, J. Pugin, 2014, The Journal of Biological Chemistry.

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis

Robert H. Jenkins, M. Eberl, A. Clayton, 2019, Scientific Reports.

Targeting the TLR Co-Receptor CD14 with TLR2-Derived Peptides Modulates Immune Responses to Pathogens

Judith E. Hall, P. Ferrara, T. Szakmany, 2013, Science Translational Medicine.

Modulation of Neonatal Microbial Recognition: TLR-Mediated Innate Immune Responses Are Specifically and Differentially Modulated by Human Milk1

Michael Affolter, M. Affolter, M. Labéta, 2006, The Journal of Immunology.

TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2

J. Köhl, M. Labéta, B. Morgan, 2011, European journal of immunology.

Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

M. Eberl, J. Köhl, M. Labéta, 2017, Journal of the American Society of Nephrology : JASN.

Soluble TLR2 Reduces Inflammation without Compromising Bacterial Clearance by Disrupting TLR2 Triggering1

Simon A. Jones, P. Brennan, M. Labéta, 2009, The Journal of Immunology.

Disrupting TLR2 Triggering Compromising Bacterial Clearance by Soluble TLR2 Reduces Inflammation without

Simon A. Jones, P. Brennan, M. Labéta, 2009 .

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis

Robert H. Jenkins, M. Eberl, A. Clayton, 2019, Scientific Reports.

Therapeutic Boosting of the Immune Response: Turning to CD14 for Help

M. Labéta, A. Raby, 2016, Current pharmaceutical biotechnology.

Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity

M. Labéta, A. Raby, 2018, Front. Physiol..

Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology

D. Ramji, M. Labéta, N. Ipseiz, 2023, Frontiers in immunology.

Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection

M. Labéta, G. Gónzalez-Mateo, A. Raby, 2023, Frontiers in cellular and infection microbiology.